Synthetic Hormones Global Market Report 2024 - By Size, Share, Demand, Trends, Forecast To 2033

"The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Synthetic Hormones Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $7.79 Bn In 2028 At A CAGR Of 5.1% :
The synthetic hormones market size has grown strongly in recent years. It will grow from $6.0 billion in 2023 to $6.38 billion in 2024 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to animal growth promotion, performance enhancement, environmental impact, fertility treatments and menopausal symptom management.

The synthetic hormones market size is expected to see strong growth in the next few years. It will grow to $7.79 billion in 2028 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to expansion of the transgender healthcare market, growing healthcare expenditure and insurance coverage, regulatory approvals, and expanding applications of synthetic hormones. Major trends in the forecast period include rise of plant-based hormone therapy, integration of hormone therapy in anti-aging treatments, technological advancements in drug delivery, and focus on hormone-free birth control.

Request A Sample Of This Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=14515&type=smp

Synthetic Hormones Market Major Segments
The synthetic hormones market covered in this report is segmented -
1) By Product Type: Steroid Hormones, Peptide Hormone, Amino Acid Derivatives, Other Product Types
2) By Route of Administration: Oral, Nasal, Topical, Intravenous
3) By Application: Growth Hormone Deficiency, Thyroid Hormone Deficiency, Menopause, Male Hypogonadism, Other Applications
4) By End User: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Key Driver - Rising Incidence Of Hormonal Imbalances Fuels Growth In The Synthetic Hormone Market

The increasing incidence of hormonal imbalances is expected to propel the growth of the synthetic hormones market going forward. A hormonal imbalance refers to having too much or too little of a hormone in the blood, which can occur due to stress, aging, medical conditions, or lifestyle choices, disrupting the average production and regulation of hormones in the body. Synthetic hormones are used to supplement or replace natural hormones in hormonal imbalances, helping regulate bodily functions and alleviate symptoms associated with deficiencies or excesses. For instance, according to the NHS Business Services Authority, a UK-based non-departmental public body, in 2022, around 7.80 million hormone replacement therapy (HRT) items were prescribed in England, marking a 35.0% increase from the previous year. Therefore, the increasing incidence of hormonal imbalances is driving the growth of the synthetic hormones market.

Customise This Report As Per Your Requirements -
https://www.thebusinessresearchcompany.com/Customise?id=14515&type=smp

Prominent Trend - Development Of Long-Acting Recombinant Human Growth Hormone Products Enhances Market Profitability
Major companies operating in the synthetic hormone market are focused on developing innovative products, such as recombinant human growth hormone, to increase their profitability in the market. Recombinant human growth hormone is a synthetic hormone used to treat growth hormone deficiency in children and adults, as well as certain medical conditions associated with growth hormone deficiency. For instance, in February 2022, Pfizer Inc., a US-based pharmaceutical company, and OPKO Health Inc., a US-based medical test and medication company, received marketing authorization for once-weekly NGENLA (somatrogon) injections in the European Union. These injections are intended to treat pediatric growth hormone deficiency in children and adolescents at least three years old. This new long-acting injection provides an alternative for individuals with growth disturbances caused by insufficient growth hormone secretion. NGENLA is administered subcutaneously and lasts longer in the body than daily growth hormone injections, making it possible to help it once a week.

Synthetic Hormones Market Players
Major companies operating in the synthetic hormones market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bristol Myers Squibb Company, Sanofi SA, AstraZeneca PLC, Novartis AG, GlaxoSmithKline PLC, Gilead Sciences Inc., Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Merck & Co. Inc., Teva Pharmaceutical Industries Ltd., Ferring B.V., Endo Pharmaceuticals Inc., Lupin Pharmaceuticals Inc., IBSA Institute Biochimique SA, American Regent Inc., McGuff Pharmaceuticals Inc., Anhui Anke Biotechnology Co.Ltd., Lyndra Therapeutics Inc., Acerus Pharmaceuticals Corporation, Arch BioPartners Inc., Slayback Pharma LLC

View The Full Report Here -
https://www.thebusinessresearchcompany.com/report/synthetic-hormones-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the synthetic hormones market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the synthetic hormones market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Synthetic Hormones Market Report Structure
3. Synthetic Hormones Market Trends And Strategies
4. Synthetic Hormones Market - Macro Economic Scenario
5. Synthetic Hormones Market Size And Growth
…..
27. Synthetic Hormones Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ"

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.